Back to JPMorgan Chase & Co. JPMorgan Chase & Co.

ETON

8 quarters

Position history for JPMorgan Chase & Co.JPMorgan Chase & Co.'s holdings in Eton Pharmaceuticals, Inc.

Yes. JPMorgan Chase holds 191,635 shares of ETON (Eton Pharmaceuticals), worth $7M, as of its Q2 2026 13F filing. It increased the position by 21,759 shares (+12.8%) from Q1 2026. JPMorgan Chase has held ETON in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$7M

Current Shares

191,635

Total Value Change

+$7M

Total Shares Change

+190,912

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
191,635
+12.8%
$7M0.0%$36.20
31
2026-Q1
Decreased
169,876
-8.4%
$3.8M0.0%$24.68
0
2025-Q4
Decreased
185,439
-47.2%
$3.1M0.0%$16.91
0
2025-Q3
Increased
351,417
+44.9%
$7.6M0.0%$21.73
37
2025-Q2
Increased
242,580
+114.5%
$3.5M0.0%$14.25
43
2025-Q1
Increased
113,113
+117.7%
$1.5M0.0%$12.98
41
2024-Q4
Increased
51,961
+7086.9%
$692,1210.0%$13.32
40
2024-Q3
First report
723
-
$4,3380.0%$6.00
0

Other major holders of ETON: BlackRock, Inc., Vanguard Capital Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used